<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">J Pathol</journal-id>
        <journal-id journal-id-type="iso-abbrev">J Pathol</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>The Journal of pathology</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">0022-3417</issn>
        <issn pub-type="epub">1096-9896</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC10756077</article-id>
        <article-id pub-id-type="pmcid-ver">PMC10756077.319</article-id>
        <article-id pub-id-type="pmcaid">10756077</article-id>
        <article-id pub-id-type="pmcaiid">10756077</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1939812</article-id>
        <article-id pub-id-type="pmid">37350195</article-id>
        <article-id pub-id-type="doi">10.1002/path.6137</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1939812</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1939812</article-id>
        <article-version article-version-type="pmc-version">319</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dermawan</surname>
              <given-names initials="JK">Josephine K.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chi</surname>
              <given-names initials="P">Ping</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Tap</surname>
              <given-names initials="WD">William D.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rosenbaum</surname>
              <given-names initials="E">Evan</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>D’Angelo</surname>
              <given-names initials="S">Sandra</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Alektiar</surname>
              <given-names initials="KM">Kaled M.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Antonescu</surname>
              <given-names initials="CR">Cristina R.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A2"><label>2</label>Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A3"><label>3</label>Department of Medicine, Weill Cornell Medical College, New York, NY, USA</aff>
        <aff id="A4"><label>4</label>Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <author-notes>
          <fn fn-type="con" id="FN1">
            <p id="P1">Author contributions statement</p>
            <p id="P2">JKD performed study design, data acquisition, data analysis and interpretation, writing and revision of the paper. PC, WDT, ER, SDA and KMA performed data acquisition and critical review of the paper. CRA performed study design and conception, analysis and interpretation of data, writing, review and revision of paper. All authors read and approved the final manuscript.</p>
          </fn>
          <corresp id="CR1"><label>*</label><bold>Correspondence to:</bold> CR Antonescu, Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. <email>antonesc@mskcc.org</email></corresp>
          <fn fn-type="COI-statement" id="FN2">
            <p id="P51">No conflicts of interest were declared</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <month>8</month>
          <year>2023</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>23</day>
          <month>6</month>
          <year>2023</year>
        </pub-date>
        <volume>260</volume>
        <issue>4</issue>
        <issue-id pub-id-type="pmc-issue-id">451852</issue-id>
        <fpage>465</fpage>
        <lpage>477</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>29</day>
              <month>11</month>
              <year>2023</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>01</day>
              <month>08</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>01</day>
              <month>08</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-08-01 00:25:14.000">
              <day>01</day>
              <month>08</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1939812.pdf"/>
        <abstract id="ABS1">
          <p id="P3"><italic toggle="yes">MYC</italic> amplifications have been frequently detected in radiation (RT)-associated angiosarcomas (ASs) by low resolution molecular methods. However, large-scale next-generation sequencing (NGS) studies to investigate- the genomic landscape of RT-AS are scarce, particularly compared with other RT-associated sarcomas. We perform a detailed comparative genomic investigation of RT-AS versus other RT-associated histotypes, as well as sporadic sarcomas with similar histologies. Our institutional targeted DNA-NGS assay database was searched for RT-associated sarcomas. Clinical outcome data, pathologic diagnosis, and the types and frequencies of genomic alterations, including single nucleotide variants (SNV) and copy number alterations (CNA), were analyzed. The cohort consisted of 82 patients, 68 (83%) females and 14 (17%) males, aged 37–88 years old (mean 64). Forty-four RT-AS (38 from breast) and 38 RT-sarcomas of other histologies: including 12 malignant peripheral nerve sheath tumors (RT-MPNST), 14 undifferentiated pleomorphic sarcomas (RT-UPS) and 12 osteosarcoma (RT-OS), were included. Median time intervals from radiation to initial diagnosis in RT-AS (8.0 years) were significantly lower than those in RT-MPNST and RT-UPS (12.5 and 18.5 years), respectively. Each RT-sarcoma histotypes harbored distinct mutations and CNA. RT-associated AS had more frequent <italic toggle="yes">MYC</italic>, <italic toggle="yes">FLT4</italic>, <italic toggle="yes">CRKL, HRAS</italic>, and <italic toggle="yes">KMT2D</italic> alterations than sporadic AS (enriched in <italic toggle="yes">TP53</italic>, <italic toggle="yes">KDR</italic>, <italic toggle="yes">ATM</italic>, <italic toggle="yes">ATRX</italic>), whereas the mutational landscapes of MPNST, UPS, and OS were similar in both RT and non-RT settings. <italic toggle="yes">CDKN2A/B</italic> deletions and <italic toggle="yes">TP53</italic> alterations were infrequent in RT-AS compared to other RT-sarcomas. Among RT-sarcomas, RT-AS harbored the lowest fraction of genome altered (FGA), while RT-MPNST showed the highest FGA. RT-AS had the lowest insertion:SNV and deletion:SNV ratios, while RT-UPS has the highest. The predominant mutational signatures were associated with errors in DNA repair and replication. In conclusion, RT-AS has distinct genomic landscape compared to other RT-sarcomas and sporadic AS. Potential molecular targets for precision medicine may be histotype-dependent.</p>
        </abstract>
        <kwd-group>
          <kwd>radiation-associated</kwd>
          <kwd>angiosarcoma</kwd>
          <kwd>MPNST</kwd>
          <kwd>osteosarcoma</kwd>
          <kwd>undifferentiated pleomorphic sarcoma</kwd>
          <kwd>molecular profiling</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
